RASSF6 is a novel member of the RASSF family of tumor suppressors

Oncogene

Volumn 26, Issue 42, 2007, Pages 6203-6211

  Allen, N P C ^a   Donninger, H ^b   Vos, M D ^a   Eckfeld, K ^a   Hesson, L ^c   Gordon, L ^b   Birrer, M J ^a   Latif, F ^c   Clark, G J ^a,b,d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

Ras; RASSF6; Tumor suppressor

Indexed keywords

K RAS PROTEIN; RAS ASSOCIATED DOMAIN FAMILY PROTEIN 6; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL KILLING; CONTROLLED STUDY; DOWN REGULATION; FUNCTIONAL PROTEOMICS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR CELL;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH INHIBITORS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MONOMERIC GTP-BINDING PROTEINS; MULTIGENE FAMILY; ORGAN SPECIFICITY; RAS PROTEINS; TUMOR SUPPRESSOR PROTEINS;

RESPIRATORY SYNCYTIAL VIRUS;

EID: 34548674452     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210440     Document Type: Article

References (39)

1. Agathanggelou A, Cooper WN, Latif F. (2005). Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res 65: 3497-3508.
2. Akino K, Toyota M, Suzuki H, Mita H, Sasaki Y, Ohe-Toyota M et al. (2005). The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer. Gastroenterology 129: 156-169.
3. Baksh S, Tommasi S, Fenton S, Yu VC, Martins LM, Pfeifer GP et al. (2005). The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death. Mol Cell 18: 637-650.
4. Bitko V, Garmon NE, Cao T, Estrada B, Oakes JE, Lausch RN et al. (2004). Activation of cytokines and NF-kappa B in corneal epithelial cells infected by respiratory syncytial virus: potential relevance in ocular inflammation and respiratory infection. BMC Microbiol 4: 28.
5. Burbee DG, Forgacs E, Zochbauer-Muller S, Shivakumar L, Fong K, Gao B et al. (2001). Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 93: 691-699.
6. Chen J, Lui WO, Vos MD, Clark GJ, Takahashi M, Schoumans J et al. (2003). The t(1;3) breakpoint-spanning genes LSAMP and NORE1 are involved in clear cell renal cell carcinomas. Cancer Cell 4: 405-413.
7. Clark GJ, Drugan JK, Terrell RS, Bradham C, Der CJ, Bell RM et al. (1996). Peptides containing a consensus Ras binding sequence from Raf-1 and theGTPase activating protein NF1 inhibit Ras function. Proc Natl Acad Sci USA 93: 1577-1581.
8. Cox AD, Der CJ. (2003). The dark side of Ras: regulation of apoptosis. Oncogene 22: 8999-9006.
9. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. (2000). Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 25: 315-319.
10. Diep CB, Teixeira MR, Thorstensen L, Wiig JN, Eknaes M, Nesland JM et al. (2004). Genome characteristics of primary carcinomas, local recurrences, carcinomatoses, and liver metastases from colorectal cancer patients. Mol Cancer 3: 6.
11. Eckfeld K, Hesson L, Vos MD, Bieche I, Latif F, Clark GJ. (2004). RASSF4/AD037 is a potential ras effector/tumor suppressor of the RASSF family. Cancer Res 64: 8688-8693.
12. Ellis CA, Vos MD, Howell H, Vallecorsa T, Fults DW, Clark GJ. (2002). Rig is a novel Ras-related protein and potential neural tumor suppressor. Proc Natl Acad Sci USA 99: 9876-9881.
13. Feig LA, Buchsbaum RJ. (2002). Cell signaling: life or death decisions of ras proteins. Curr Biol 12: R259-R261.
14. Fiordalisi JJ, Johnson RL 2nd, Ulku AS, Der CJ, Cox AD. (2001). Mammalian expression vectors for Ras family proteins: generation and use of expression constructs to analyze Ras family functions. Meth Enzymology 332: 3-36.
15. Frame S, Balmain A. (2000). Integration of positive and negative growth signals during ras pathway activation in vivo. Curr Opin Genet Dev 10: 106-113.
16. Hueber AO, Evan GI. (1998). Traps to catch unwary oncogenes. Trends Genet 14: 364-367.
17. Hull J, Rowlands K, Lockhart E, Sharland M, Moore C, Hanchard N et al. (2004). Haplotype mapping of the bronchiolitis susceptibility locus near IL8. Hum Genet 114: 272-279.
18. Khokhlatchev A, Rabizadeh S, Xavier R, Nedwidek M, Chen T, Zhang XF et al. (2002). Identification of a novel Ras-regulated proapoptotic pathway. Curr Biol 12: 253-265.
19. Malumbres M, Barbacid M. (2003). RAS oncogenes: the first 30 years. Nat Rev Cancer 3: 459-465.
20. Malumbres M, Pellicer A. (1998). RAS pathways to cell cycle control and cell transformation. Front Biosci 3: d887-d912.
21. Marshall MS. (1993). The effector interactions of p21ras. Trends Biochem Sci 18: 250-254.
22. Mayo MW, Wang CY, Cogswell PC, Rogers-Graham KS, Lowe SW, Der CJ et al. (1997). Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 278: 1812-1815.
23. Nicke B, Bastien J, Khanna SJ, Warne PH, Cowling V, Cook SJ et al. (2005). Involvement of MINK, a Ste20 family kinase, in Ras oncogene-induced growth arrest in human ovarian surface epithelial cells. Mol Cell 20: 673-685.
24. Okada T, Masuda T, Shinkai M, Kariya K, Kataoka T. (1996). Post-translational modification of H-Ras is required for activation of, but not for association with, B-Raf. J Biol Chem 271: 4671-4678.
25. Pfeifer GP, Yoon JH, Liu L, Tommasi S, Wilczynski SP, Dammann R. (2002). Methylation of the RASSF1A gene in human cancers. Biol Chem 383: 907-914.
26. Ponting DP, Benjamin DR. (1996). A novel family of Ras-binding domains. Trends Biochem Sci 21: 422-425.
27. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. (1997). Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593-602.
28. Shields JM, Pruitt K, McFall A, Shaub A, Der CJ. (2000). Understanding Ras: 'it ain't over 'til it's over'. Trends Cell Biol 10: 147-154.
29. Smyth RL, Openshaw PJ. (2006). Bronchiolitis. Lancet 368: 312-322.
30. Solski PA, Quilliam LA, Coats SG, Der CJ, Buss JE. (1995). Targeting proteins to membranes using signal sequences for lipid modification. Methods Enzymol 250: 435-454.
31. Tommasi S, Dammann R, Jin SG, Zhang XX, Avruch J, Pfeifer GP. (2002). RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1. Oncogene 21: 2713-2720.
32. Tommasi S, Dammann R, Zhang Z, Wang Y, Liu L, Tsark WM et al. (2005). Tumor susceptibility of Rassf1a knockout mice. Cancer Res 65: 92-98.
33. Vos MD, Dallol A, Eckfeld K, Allen NP, Donninger H, Hesson L et al. (2006). The RASSF1A tumor suppressor activates Bax via MOAP-1. J Biol Chem 281: 4557-4563.
34. Vos MD, Ellis CA, Bell A, Birrer MJ, Clark GJ. (2000). Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J Biol Chem 275: 35669-35672.
35. Vos MD, Ellis CA, Elam C, Ulku AS, Taylor BJ, Clark GJ. (2003a). RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor. J Biol Chem 278: 28045-28051.
36. Vos MD, Martinez A, Elam C, Dallol A, Taylor BJ, Latif F et al. (2004). A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stability. Cancer Res 64: 4244-4250.
37. Vos MD, Martinez A, Ellis CA, Vallecorsa T, Clark GJ. (2003b). The pro-apoptotic Ras effector Nore1 may serve as a Ras-regulated tumor suppressor in the lung. J Biol Chem 278: 21938-21943.
38. White MA, Nicolette C, Minden A, Polverino A, Van AL, Karin M et al. (1995). Multiple Ras functions can contribute to mammalian cell transformation. Cell 80: 533-541.
39. Williams JG, Drugan JK, Yi GS, Clark GJ, Der CJ, Campbell SL. (2000). Elucidation of binding determinants and functional consequences of Ras/Raf-cysteine-rich domain interactions. J Biol Chem 275: 22172-22179.